Veru Depreciation & Amortization 2011-2026 | VERU

Annual Depreciation & Amortization Veru

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
268 K	270 K	138 K	98 K	146 K	309 K	177 K	334 K	423 K	494 K	589 K	556 K	461 K	465 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
589 K	98 K	338 K

Quarterly Depreciation & Amortization Veru

2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
28.2 K	-	29 K	29 K	64.9 K	-	32 K	32 K	72.1 K	-	53 K	45 K	45 K	94 K	39 K	30 K	25 K	75 K	21 K	22 K	32 K	237 K	79 K	60 K	79 K	232 K	77 K	79.1 K	42.6 K	206 K	69 K	77.3 K	44.2 K	267 K	177 K	44.2 K	89.3 K	328 K	227 K	89.3 K	114 K	373 K	251 K	114 K	128 K	429 K	287 K	128 K	144 K	418 K	274 K	144 K	131 K	342 K	225 K	131 K	112 K	350 K	234 K	112 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
429 K	21 K	135 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
China Pharma Holdings CPHI	2.62 M	$ 0.57	-9.62 %	$ 9.95 M	China
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Emergent BioSolutions EBS	125 M	$ 8.01	-0.5 %	$ 410 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.13	2.62 %	$ 44 M	USA
Neoleukin Therapeutics NLTX	3.04 M	-	-	$ 193 M	Canada
Bausch Health Companies BHC	1.26 B	$ 4.99	-2.25 %	$ 1.82 B	Canada
Pacira BioSciences PCRX	78.8 M	$ 23.2	2.43 %	$ 1.07 B	USA
Harrow Health HROW	1.32 M	$ 35.2	3.53 %	$ 1.29 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Perrigo Company plc PRGO	338 M	$ 9.64	0.73 %	$ 1.34 B	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Evolus EOLS	7.51 M	$ 4.43	-5.34 %	$ 286 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Rockwell Medical RMTI	1.44 M	$ 1.03	0.98 %	$ 24 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 6.1	4.1 %	$ 241 M	USA
SCYNEXIS SCYX	580 K	$ 0.9	2.8 %	$ 44.9 M	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
Solid Biosciences SLDB	1.64 M	$ 6.68	-6.44 %	$ 585 M	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.34	-8.24 %	$ 2.9 M	USA
Organogenesis Holdings ORGO	13.6 M	$ 2.41	-2.43 %	$ 317 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 0.96	-0.87 %	$ 103 M	Canada
Tilray TLRY	35.7 M	$ 6.66	3.26 %	$ 4.12 B	Canada
Assertio Holdings ASRT	30 M	$ 16.51	17.93 %	$ 106 M	USA
TherapeuticsMD TXMD	922 K	$ 2.29	-0.87 %	$ 23.9 M	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Viatris VTRS	2.74 B	$ 13.36	0.53 %	$ 16 B	USA
cbdMD YCBD	452 K	$ 0.77	1.06 %	$ 3.32 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA